Abstract: Erythema elevatum diutinum is a rare chronic leukocytoclastic vasculitis of unknown etiology. It is believed to be due to deposition of immune complexes in the vessels. Clinically it is manifested as erythematous violaceous papules and nodules, isolated or confl uent with hardened consistency, symmetrical, usually located on the extensor surface of the extremities, particularly over the joints. Diagnosis is based on clinical and histological fi ndings. We report the case of a woman, 71 years old, with erythematous violaceous nodules on the hands, elbows, back and legs, beginning two years ago, with pain and itching. Histopathological analysis revealed leukocytoclastic vasculitis, confi rming the clinical suspicion. Laboratory tests revealed hypothyroidism. We report the case because of its rarity, with subsequent review of the literature.
INTRODUCTION
The erythema elevatum diutinum (EED) is a rare chronic leukocytoclastic vasculitis of unknown etiology, characterized by the absence of systemic vasculopathy.
1 It was fi rst described by Hutchinson in 1878 and by Bury in 1889. Its name was given by Radcliffe-Crocker and Williams in 1894. 1, 2, 3 Clinically it is manifested by erythematous violaceous papules and nodules, isolated or confl uent, in hardened, symmetrical plaques predominantly on the extensor surface of extremities, mainly over the joins. The diagnosis is based on clinical and histological fi ndings. In view of its rarity, a case of EED and hypothyreoidism is here reported.
CASE REPORT
The case of a 71-year-old woman is reported. She presented erythematous violaceous papules on the back and buttocks; hardened, symmetrical erythematous violaceous nodules, some ulcerated, on the elbows, hands and feet; and ulcerated malleolar tumoral lesion for two years, accompanied by pain and pruritus (Figures 1 to 3) . The patient mentioned progressive increase of lesions. The histopathological examination evidenced intense dermal neutrophilic infi ltrate, diffuse and permeating vessel walls, which showed fi brinoid alterations and occasional leukocytoclasia, compatible with leukocytoclastic vasculitis (Figure 4 ). Laboratory investigation included complete blood count, renal, hepatic and thyroid function, protein electrophoresis, serologies for syphilis, HIV and hepatitides, rheumatoid factor, antinuclear antibody, glycemia, P-ANCA and C-ANCA, all without abnormal results except for TSH and free T4, compatible with hypothyreoidism and high levels of anti-thyroglobulin and anti-peroxidase antibodies. Abdominal and transvaginal ultrasound, colonoscopy and X-ray of the thorax and long bones had normal results. The data revealed in the tests confi rmed the EED diagnosis and the treatment was begun with dapsone, intralesional corticosteroids and levothyroxine. The patient is being followed and presents unsatisfactory response to therapy.
DISCUSSION
The EED is a rare, chronic leukocytoclastic vasculitis of unknown etiology. An association with hematologic diseases, such as monoclonal gamopathy, non-Hodgkin lymphoma, chronic lymphocytic leukemia and multiple myeloma; autoimmune diseases, such as rheumatoid arthritis, celiac disease, systemic lupus erythematosus, Sjögren syndrome, antiphospholipid antibody syndrome, pyoderma gangrenosum, diabetes mellitus type 1 and hypothyroidism; neoplastic diseases, as breast and lung cancer; and infectious diseases, as streptococcus infection, HIV and hepatitides. [1] [2] [3] [4] It is presumed that the pathogenesis is related to deposition of immune complexes on vessel walls, activation of the complement cascade, neutrophil chemotaxis, excessive premature expression of proinfl ammatory cytokines, releasing lysozymes, collagenase, myeloperoxidase and hydrolases that induce deposition of fi brin inside and around the vessels. 3, 5, 6, 7 It is clinically manifested by erythematous violaceous papules and nodules, isolated or confl uent in plaques, of hardened consistency; at fi rst they are soft, gradually becoming hardened and symmetrical, predominantly on the extensor surface of the extremities, mainly over the joints of hands, elbows, knees and ankles. Lesions have already been described on the trunk and retroauricular region. 2 There are atypical forms of presentation with vesicles, ulcers and hemorrhagic nodules. 2 The partial resolution may impart a yellowish or brownish tone to the lesions, which take on the appearance of xanthomas. The lesions may resolve without scars or result in atrophy and depigmentation. The clinical picture is usually asymptomatic, but in some cases, the onset of lesions is associated with itching and burning sensations. 1 Arthralgia and fever may be present. In cases associated with infection by HIV, the lesions are predominantly nodular and there is a palmoplantar involvement. 2 The diagnosis is based on these clinical fi ndings and on the histological picture that revealed leukocytoclastic vasculitis with neutrophilic infi ltrate and fi brin deposit on the walls of small dermal vessels. In the beginning stage, polymorphonuclear infi ltrate, macrophages, histiocytes and, more rarely, eosinophils may be found in perivascular sites. During the disease progression, histiocytes become proportionally the majority in the infl ammatory infi ltrate. Older lesions reveal a combination of granulation response and skin healing, with dermal proliferation of fusiform cells, associated or not to multinucleated giant cells. Vascular damage is demonstrated by the presence of dilated blood vessels with hypertrophic endothelial cells, projected to the lumen of the vessel. 2 The differential diagnosis of EED is quite wide and includes Sweet Syndrome, pyoderma gangrenosum, facial granuloma, fi xed drug eruption, erythema multiforme, bullous pemphigoid, porphyria cutanea tarda, multicentric reticulohistiocytosis, rheumatoid nodules, dermatofi broma, bacillary angiomatosis, Kaposi sarcoma and xanthoma. EED is a chronic disease, with relapses, making its treatment diffi cult. The drug of fi rst choice is dapsone, for its inhibitory effect on the chemotaxis of neutrophils, but it is common for the patient to experience recurrence of lesions after the end of treatment and it seems less effective on fi brotic lesions. 2 In these cases, the association of dapsone and surgical excision showed good results. 6 Other therapeutic options described in the literature include nicotinamide, tetracycline, colchicine, niacinamide, chloroquine and cyclosporine. 1, 2, 3 The use of cyclosporine in association with dapsone seems to have an additive or synergistic effect and may be an alternative for recalcitrant cases. 8 High potency and intralesional topical corticoids may be very effective to reduce lesion size and are the treatment of choice for localized cases. 5 In positive HIV patients, the association with the antiretroviral therapy seems to be effective. 2, 9 A typical case is reported, from the anatomo-clinical point of view, of EED associated with hypothyroidism, corroborating a report in the literature of Hashimoto thyroiditis as a possible autoimmune disease related to EED. 10 As regards neoplasms, complete regression of cutaneous lesions has already been reported after treatment, and some authors suggest that the erythema elevatum diutinum is a paraneoplastic syndrome that may even precede by years hematologic malignancies. 4 Therefore, medical follow-up is extremely important to outwit possible neoplasms. When an association with another disease is established, it should be treated. Although having a chronic and persistent character, some cases spontaneously in a fi ve to ten-year period. 4 
